Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Safety and tolerability of Capecitabine and Aflibercept in patients with unresectable metastatic colorectal cancer deemed unsuitable for doublet/ triplet chemotherapy

ABSTRACT: See http://www.cancerresearchuk.org/about-cancer/trials/a-trial-looking-at-capecitabine-aflibercept-bowel-cancer-spread-elsewhere-in-the-body-capital

DISEASE(S): Rectum,Colorectal Cancer

PROVIDER: 2408012 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Surgical timing after radiotherapy for rectal cancer

Project description:See http://www.cancerresearchuk.org/cancer-help/trials/a-trial-looking-surgery-following-treatment-rectal-cancer-starrcat

| 2425520 | ecrin-mdr-crc

Streamlining Staging of Colorectal cancer with Whole Body MRI

Project description:See http://www.cancerresearchuk.org/cancer-help/trials/a-study-looking-mri-scan-diagnose-bowel-cancer-streamline-c

| 2417665 | ecrin-mdr-crc

CRIB (Cancer Rehabilitation In Bowel cancer): the use of cardiac rehabilitation services to aid the recovery of colorectal cancer patients: a pilot randomised controlled trial (RCT) with embedded feasibility study

Project description:See http://www.cancerresearchuk.org/cancer-help/trials/a-trial-looking-exercise-programme-after-bowel-cancer-surgery-crib

| 2421110 | ecrin-mdr-crc

The impact of combined modality positron emission tomography with computerised tomography scanning (PET/CT) in the diagnosis and management of pancreatic cancer

Project description:See http://www.cancerresearchuk.org/about-cancer/trials/a-study-looking-pet-ct-scans-diagnose-cancer-pancreas-pet-panc

| 2422886 | ecrin-mdr-crc

ESPAC-5: European Study group for Pancreatic Cancer - Trial 5

Project description:See http://www.cancerresearchuk.org/cancer-help/trials/a-study-looking-at-chemotherapy-or-chemoradiotherapy-before-surgery-for-pancreatic-cancer-espac-5f

| 2425622 | ecrin-mdr-crc

Study to assess the delivery of a lifestyle intervention for colorectal cancer patients undergoing potentially curative treatment

Project description:See http://www.cancerresearchuk.org/cancer-help/trials/a-study-looking-at-giving-lifestyle-advice-to-people-having-treatment-for-bowel-cancer-treatwell

| 2419163 | ecrin-mdr-crc

Finding the best dose of aspirin to prevent Lynch Syndrome cancers

Project description:See http://www.cancerresearchuk.org/about-cancer/trials/a-trial-looking-at-different-doses-of-aspirin-to-prevent-cancer-in-people-with-lynch-syndrome-capp3

| 2411902 | ecrin-mdr-crc

Expression profiling of mouse liver after treatment with Vascular Endothelial Growth Factor (VEGF) inhibitor aflibercept

Project description:Transcriptional profiling of mouse liver was compared between VEGF inhibitor aflibercept and control treatment after 9 weeks. 8-10 week-old SCID mice received VEGF Trap protein (aflibercept) subcutaneously twice per week at 25mg per kg body weight for 9 weeks. For control groups, mice were treated with humanized Fc (Regeneron). 5 biological replicates were performed for the control group and 4 biological replicates were performed for the treatment group

2013-09-01 | E-GEOD-50519 | biostudies-arrayexpress

Alternative chemotherapy for frail or elderly patients with advanced gastric or oesophageal cancer

Project description:See http://www.cancerresearchuk.org/cancer-help/trials/a-trial-looking-at-chemotherapy-for-frail-or-elderly-patients-with-advanced-cancer-of-the-stomach-or-food-pipe-go2

| 2417793 | ecrin-mdr-crc

Expression profiling of mouse liver after treatment with Vascular Endothelial Growth Factor (VEGF) inhibitor aflibercept

Project description:Transcriptional profiling of mouse liver was compared between VEGF inhibitor aflibercept and control treatment after 9 weeks.

2013-09-01 | GSE50519 | GEO